![Robert Jacks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Jacks
Amministratore Delegato presso Sparrow Pharmaceuticals, Inc.
Posizioni attive di Robert Jacks
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sparrow Pharmaceuticals, Inc.
![]() Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sparrow Pharmaceuticals, Inc. engages in pharmaceuticals industry. It develops drugs for cushing?s syndrome. The company was founded by David A. Katz and is headquartered in Portland, OR. | Direttore/Membro del Consiglio | 01/01/2021 | - |
Amministratore Delegato | 01/01/2021 | - | |
Presidente | 01/01/2021 | - |
Storia della carriera di Robert Jacks
Precedenti posizioni note di Robert Jacks
Società | Posizione | Inizio | Fine |
---|---|---|---|
Indalo Therapeutics, Inc.
![]() Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 28/01/2019 | - |
Amministratore Delegato | 28/01/2019 | - | |
Presidente | 28/01/2019 | - | |
Symbiomix Therapeutics LLC
![]() Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Direttore Finanziario/CFO | 01/01/2012 | - |
Fondatore | 01/01/2012 | - | |
Presidente | 01/01/2012 | - | |
ACT Biotech, Inc.
![]() ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Corporate Officer/Principal | 22/12/2009 | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Paramount BioSciences LLC
![]() Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investitore di Private Equity | - | - |
Formazione di Robert Jacks
Duke University | Undergraduate Degree |
Stanford University | Graduate Degree |
Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
President | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 5 |
---|---|
Symbiomix Therapeutics LLC
![]() Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Health Technology |
Paramount BioSciences LLC
![]() Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
ACT Biotech, Inc.
![]() ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Health Technology |
Indalo Therapeutics, Inc.
![]() Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Health Technology |
Sparrow Pharmaceuticals, Inc.
![]() Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sparrow Pharmaceuticals, Inc. engages in pharmaceuticals industry. It develops drugs for cushing?s syndrome. The company was founded by David A. Katz and is headquartered in Portland, OR. | Health Technology |
- Borsa valori
- Insiders
- Robert Jacks
- Esperienza